Analystreport

Jazz Pharmaceuticals (NASDAQ: JAZZ) had its price target raised by analysts at B. Riley from $206.00 to $211.00. They now have a "buy" rating on the stock.

Jazz Pharmaceuticals plc - Ordinary Shares  (JAZZ) 
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: jazzpharma.com